Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ROCKWELL MEDICAL, INC.RMTI · Entity 7426 | Chief Development Officer | May 03, 2021 | June 03, 2021 |
| Savara IncSVRA · Entity 4900 | Chief Medical Officer | December 12, 2024 | December 16, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ROCKWELL MEDICAL, INC.
Report date May 03, 2021 · Filed June 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.94 · Expires 2031-05-03 | Direct | 112,500 |
Reported balance
After 2021-05-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-05-03 · Grant · Acquired 112,500 · Balance 112,500 F1: Stock options vest in two equal installments on the second and fourth anniversaries of May 3, 2021, subject to the Reporting Person's continued employment with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options vest in two equal installments on the second and fourth anniversaries of May 3, 2021, subject to the Reporting Person's continued employment with the Issuer.
Savara Inc
Report date December 12, 2024 · Filed December 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 340,050 |
Reported balance
After 2024-12-12 transaction · row 1
1 source rowRow 1 · 2024-12-12 · Grant · Acquired 80,000 · Balance 340,050 F1: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.35 · Expires 2034-12-12 | Direct | 280,000 |
Reported balance
After 2024-12-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-12-12 · Grant · Acquired 280,000 · Balance 280,000 F2: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 12, 2024 Filed Dec 16, 2024 22:57 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0000950170-24-136783 · ownership.xml · derivative · entry 2 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2034-12-12 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:57 UTC | Savara Inc SVRA · Entity 4900 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136783 · ownership.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,050 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| November 10, 2024 Filed Nov 12, 2024 22:17 UTC | Savara Inc SVRA · Entity 4900 | Tax withholdingCommon Stock | 49,950 | $3.97 | $198,301.50 |
DisclosureSEC source: 0000950170-24-125681 · ownership.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,050 F1 · shares: Represents shares withheld by the Issuer in connection with the reporting person's net share settlement to satisfy tax liability based upon the vesting of previously awarded restricted stock units. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:05 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001209191-23-058946 · doc4.xml · derivative · entry 2 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-12-14 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:05 UTC | Savara Inc SVRA · Entity 4900 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058946 · doc4.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,000 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 14, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| June 26, 2023 Filed Jun 27, 2023 11:00 UTC | Savara Inc SVRA · Entity 4900 | PurchaseCommon Stock | 6,500 | $2.93 | $19,045.00 |
DisclosureSEC source: 0001209191-23-039855 · doc4.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 Read SEC document |
| December 22, 2022 Filed Dec 22, 2022 20:22 UTC | Savara Inc SVRA · Entity 4900 | PurchaseCommon Stock | 3,500 | $1.54 | $5,401.90 |
DisclosureSEC source: 0001209191-22-062421 · doc4.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,500 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 21:08 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 375,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001209191-22-058356 · doc4.xml · derivative · entry 2 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2032-11-21 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of November 10, 2022, subject to the reporting person's continued service with the Issuer. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 21:08 UTC | Savara Inc SVRA · Entity 4900 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058356 · doc4.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on November 10, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 03, 2021 Filed Jun 3, 2021 20:49 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 112,500 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001628280-21-011601 · wf-form4_162275328528639.xml · derivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2031-05-03 F1 · derivative.exercise_date: Stock options vest in two equal installments on the second and fourth anniversaries of May 3, 2021, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 18:38 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 4,612 | $2.27 | $10,469.24 |
DisclosureSEC source: 0001628280-20-005498 · wf-form4_158801270225641.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · VP of Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,358 F1 · kind: Represents shares surrendered to the Issuer in satisfaction of the payment of required withholding taxes in connection with the vesting of restricted stock units. F2 · balance_after: Includes 26,667 shares of common stock underlying unvested restricted stock unit awards that vest based on the achievement of time-based milestones. Read SEC document |
| April 25, 2019 Filed Apr 30, 2019 20:30 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001104659-19-025340 · a4.xml · derivative · entry 2 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2029-04-25 F2 · derivative.exercise_date: Stock options vest in three equal installments on the first, second and third anniversaries of April 25, 2019, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| April 25, 2019 Filed Apr 30, 2019 20:30 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-025340 · a4.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,970 F1 · kind: Restricted stock units vest in three equal installments on the first, second and third anniversaries of April 25, 2019, subject to the Reporting Person's continued employment with the Issuer. F1 · shares: Restricted stock units vest in three equal installments on the first, second and third anniversaries of April 25, 2019, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:58 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | Tax withholdingCommon Stock | 76,230 | $7.20 | $548,856.00 |
DisclosureSEC source: 0001209191-17-041698 · doc4.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · VP of Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,970 F1 · shares: Shares surrendered to Company in order to satisfy withholding tax obligations. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 22:41 UTC | ROCKWELL MEDICAL, INC. RMTI · Entity 7426 | GrantCommon Stock | 68,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022663 · doc4.xml · nonDerivative · entry 1 Pratt Raymond Dennis · CIK 0001548356 · VP of Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,200 F1 · shares: Performance-based stock grant. This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, or (c) one year following the date the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.